One of the world’s largest drug manufacturers is suing a small east metro wellness center over the way it marketed and sold a ...

Nearly 4.4 million adult New Yorkers, or 30%, have obesity, but access to weight-loss medications varies based on a variety ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of the ...

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better ...

GNC CEO, Michael Costello, joins Cheddar to discuss how the wellness business is evolving and what offerings they have similar to GLP-1 drugs. Watch!

THE WHY? The Kardashians aren’t known for missing a trend and sales of GLP-1 based drugs have sky-rocketed since Novo Nordisk ...

People taking the experimental drug amycretin were found to lose almost twice as much weight over a 12-week period as the ...

These drugs work to treat diabetes and weight loss by suppressing the appetite and lowering blood sugar and A1C—which may end ...

A woman who used the semaglutide drugs Wegovy and Ozempic to lose weight and treat diabetes says the drugmaker didn't ...

Ozempic is not approved for use in weight loss, however, many people have been taking the drug for this purpose. Semaglutide was approved for weight loss purposes under another name—Wegovy—which has a ...

A slow-release form of semaglutide could allow people who use Wegovy or Ozempic to get shots once a month, instead of ...

The craze for new drugs in the GLP-1 (Glucagon-like peptide 1) and GIP (Gastric inhibitory polypeptide) analog class, better known under the trade names Ozempic and Wegovy, is remarkable ...